Skip to content

Earnings yield at other companies

CVS Health logo
CVS HealthCVS
3.2%-3.0pp
Amazon logo
AmazonAMZN
3.5%+0.3pp
Doximity logo
DoximityDOCS
4.6%+2.5pp
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
3.1%+2.7pp
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
3.8%
Cencora logo
CencoraCOR
3.3%-0.8pp

Other financials

Income statement

See full
Revenue$194.0M-4.4%
Gross profit$173.9M-8.3%
Operating income$14.0M-40.1%
Net income$1.2M-89.4%
EPS (diluted)$0.00-100%

Balance sheet

See full
Cash & equivalents$235.7M-21.7%
Total debt$541.4M0.0%
Total equity$622.0M-4.9%
Total assets$2.0B+56.0%

Cash flow

See full
Operating cash flow$11.8M+25.8%
CapEx$1.1M+700%
Free cash flow$10.7M+15.4%

Valuation

See full
Market cap$934.74M-44.5%
Enterprise value$1.24B-35.4%
P/E45.5×-13.8×
P/S1.2×-0.9×

Profitability

See full
Gross margin91.8%-2.0pp
Operating margin9.9%-0.3pp
Net margin2.6%-1.0pp
FCF margin21%+2.3pp

Returns & leverage

See full
Return on equity3.2%-1.2pp
Debt / equity0.9×0.0×
Current ratio1.5×-3.8×

Where this comes from

Calculated from GoodRx Holdings, Inc.’s reported figures.

Based on trailing twelve months.

The official record: GoodRx Holdings, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about GoodRx Holdings, Inc.'s earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is GoodRx Holdings, Inc.'s earnings yield?
GoodRx Holdings, Inc. (GDRX) reported earnings yield of 3.1% in Q1 2026.
How has GoodRx Holdings, Inc.'s earnings yield changed year-over-year?
GoodRx Holdings, Inc.'s earnings yield increased by 82.0% year-over-year, from 1.7% to 3.1%.
What is the long-term trend for GoodRx Holdings, Inc.'s earnings yield?
Over 5 years (2020 to 2025), GoodRx Holdings, Inc.'s earnings yield has grown at a 13.1% compound annual growth rate (CAGR), from -1.8% to 3.3%.
What does earnings yield mean?
Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.